| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/29/2002 | US6342368 WD-40-derived peptides and uses thereof |
| 01/29/2002 | US6342363 Death domain containing receptor 4 nucleic acids and methods |
| 01/29/2002 | US6342357 An isolated mutant dna; for diagnosis and therapy for cardiovascular disorders characterized by prolonation of the qt interval on electrocardiogram and the presence of syncope, seizures and sudden death |
| 01/29/2002 | US6342351 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 01/29/2002 | US6342229 Used in assays, in diagnostics and in immunotherap y and immunoprophylaxis |
| 01/29/2002 | US6342224 For prophylaxis and therapy of human papilloma induced tumours |
| 01/29/2002 | US6342222 Equine arteritis virus peptides, antibodies and their use in a diagnostic test |
| 01/29/2002 | US6342221 Antibody conjugate compositions for selectively inhibiting VEGF |
| 01/29/2002 | US6342220 Agonist antibodies |
| 01/29/2002 | US6342219 As anti-angiogenic and in tumor therapy |
| 01/29/2002 | CA2158575C Chlamydia vaccine and process |
| 01/29/2002 | CA2155330C Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/29/2002 | CA2075937C Anti-human plasmin-.alpha.2- plasmin inhibitor complex antibodies, hybridomas, and immunological determination method |
| 01/24/2002 | WO2002006532A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | WO2002006486A1 Fused protein with antitumor effect |
| 01/24/2002 | WO2002006482A1 Receptor protein specifically recognizing bacterial dna |
| 01/24/2002 | WO2002006456A1 Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix |
| 01/24/2002 | WO2002006340A2 Tetraspan protein and uses thereof |
| 01/24/2002 | WO2002006328A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/24/2002 | WO2002006316A2 Alpha-msh related compounds and methods of use |
| 01/24/2002 | WO2002006311A2 Olfactory g-protein coupled receptor |
| 01/24/2002 | WO2002006310A1 Peptide fructose and complex thereof with binding protein |
| 01/24/2002 | WO2002006305A1 Method of collecting viral envelope from germinating baculovirus |
| 01/24/2002 | WO2002005844A2 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | WO2002005843A2 Human rrp sequences and methods of use |
| 01/24/2002 | WO2002005838A1 Derivatives of laspartomycin and preparation and use thereof |
| 01/24/2002 | WO2002005651A1 Peroxide treated yeast extract and method of production |
| 01/24/2002 | WO2001064750A3 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 01/24/2002 | WO2001060838A3 Aids ancestral viruses and vaccines |
| 01/24/2002 | WO2001051515A3 Genes differentially expressed in breast cancer |
| 01/24/2002 | WO2001046258A3 Transporters and ion channels |
| 01/24/2002 | WO2001042465A3 Chordin-like molecules and uses thereof |
| 01/24/2002 | WO2001036977A8 Identification of disease markers involving mass-based-separation |
| 01/24/2002 | WO2001036470A3 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 01/24/2002 | WO2001032910A3 27 human secreted proteins |
| 01/24/2002 | WO2001025436A3 Endozepine-like polypeptides and polynucleotides encoding same |
| 01/24/2002 | WO2001023409A8 38 human secreted proteins |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001016290A3 Dna encoding the human serine protease eos |
| 01/24/2002 | WO2001014417A3 Pesticidal proteins |
| 01/24/2002 | WO2001000787A3 Methods of treatment using lig 72a and variants thereof |
| 01/24/2002 | WO2000073453A9 T-bet compositions and methods of use thereof |
| 01/24/2002 | WO2000073338A9 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 01/24/2002 | US20020010325 Complexing; purified polypeptide |
| 01/24/2002 | US20020010324 Genetic engineering; polypeptides |
| 01/24/2002 | US20020010320 Chemeric and humanized antibodies to angiogenin |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010136 Having an increased positive regulatory activity for expression of tyrosine phenol lyase gene, a gene coding for the same; biosynthesis of L-3,5-dihydroxyphenylalanine (L-DOPA) |
| 01/24/2002 | US20020009781 Methods for recombinant peptide production |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009773 Nucleotide sequences coding protein associated with apoptosis; for use in treatment of defects of apoptosis and inflammation |
| 01/24/2002 | US20020009772 Novel human calcium channels and related probes, cell lines and mehtods |
| 01/24/2002 | US20020009750 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009450 Administering antagonist to surface receptors |
| 01/24/2002 | US20020009442 Diagnosis, therapy Aids |
| 01/24/2002 | US20020009435 Polypeptides having haloperoxidase activity |
| 01/24/2002 | DE10033353A1 Identifying compounds that modify activity of signal transduction pathways, useful potentially as therapeutic agents, by screening with cells that contain hybrid G proteins |
| 01/24/2002 | DE10030466A1 Nukleotid- und Aminosäurensequenzen eines zellulären Repressors der DNA Replikation des Herpesvirus Epstein-Barr Nucleotide and amino acid sequences of a cellular repressor of DNA replication of the herpes virus Epstein-Barr |
| 01/24/2002 | CA2450747A1 Derivatives of laspartomycin and preparation and use thereof |
| 01/24/2002 | CA2450372A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics |
| 01/24/2002 | CA2418207A1 Dendritic cell-derived nucleic acids and related compositions and methods |
| 01/24/2002 | CA2416452A1 Novel proteins and nucleic acids encoding same |
| 01/24/2002 | CA2416445A1 Human rrp sequences and methods of use |
| 01/24/2002 | CA2416179A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | CA2415938A1 Alpha-msh related compounds and methods of use |
| 01/24/2002 | CA2415713A1 Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix |
| 01/24/2002 | CA2415712A1 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | CA2415690A1 Tetraspan protein and uses thereof |
| 01/24/2002 | CA2415687A1 Novel g-protein coupled receptor |
| 01/23/2002 | EP1174509A1 Novel cytidine deaminase |
| 01/23/2002 | EP1174503A1 Novel proteins, gene encoding the same and method of utilization thereof |
| 01/23/2002 | EP1174502A1 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/23/2002 | EP1174441A2 Antibodies and fv fragment recognizing antigen ior c2 |
| 01/23/2002 | EP1174148A1 Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same |
| 01/23/2002 | EP1173592A1 Microbial protein expression system |
| 01/23/2002 | EP1173591A2 Pesticidal fusions |
| 01/23/2002 | EP1173590A2 Zymogen activation system |
| 01/23/2002 | EP1173587A1 Dsp-10 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173586A1 Dsp-8 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173573A1 Method for down-regulating il5 activity |
| 01/23/2002 | EP1173572A2 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173568A2 Laminin 2 and methods for its use |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173565A1 Adipocyte complement related protein homolog zacrp3 |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173556A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such |
| 01/23/2002 | EP1173547A2 Dwf4 polynucleotides, polypeptides and uses thereof |
| 01/23/2002 | EP1173546A1 A (bacillus) protein production cell |
| 01/23/2002 | EP1173486A1 Antibodies that recognize app cleaved by caspases and methods of use |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173473A1 Antifungal agents isolated from pseudomonas syringae |
| 01/23/2002 | EP1173471A2 Pseudomycin analogs |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173461A1 50 human secreted proteins |